MedTrace Logo

Dokimos Plus Aortic Valve Implant in 80 Patients Diagnosed With a Heart Valve Disease and Requiring Valve Replacement

NCT04370041 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2022-12-20

No results posted yet for this study

Summary

This study intends to reinforce the current clinical information regarding safety and efficacy of the Dokimos Plus aortic valve prosthesis in patients in whom an aortic valve replacement with a bioprosthesis has been indicated.

Conditions

  • Stenosis
  • Regurgitation, Aortic

Interventions

DEVICE

Dokimos Plus aortic valve

Dokimos Plus aortic valve

Sponsors & Collaborators

  • Swan Medical S. L.

    lead INDUSTRY

Principal Investigators

  • Christian Muñoz · Head of Cardiac Surgery Service in the Hospital GT i Pujol, Badalona, Barcelona

  • Manuel Castellà · Head of Cardiac Surgery Service in the Hospital Clínic de Barcelona

  • Albert Miralles · Head of Cardiac Surgery Service in HU. de Bellvitge, Hospitalet de Ll, Barcelona

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-02
Primary Completion
2022-11-04
Completion
2022-11-04

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04370041 on ClinicalTrials.gov